CompletedNo phase
Ceramic-on-Ceramic (COC) 36mm Acetabular Bearing Insert Post Approval Study-New Subjects (COC36mmPAS)
Key facts
- Who runs it
- DePuy Orthopaedics
- Where
- Boston, Columbus, Denver, Durham, Louisville, Philadelphia, Sacramento, and Tampa, United StatesSee the 9 sitesAlso in 1 other country, 4 sites
- Trial code
- Status
- Completed
- People taking part
- 172 people enrolled
- Started
- 1 Jun 2014
- Ended
- 31 Dec 2023
- Type of study
- Interventional
- Treatments tested
- COC 36mm
- Record updated
- 16 July 2025
Who can take part
- Age
- 21 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 22 criteriaShow less
Who can take part
- Males and females between 21 - 75 at the time of surgery
- Individuals, who in the opinion of the investigator, are suitable candidates for primary total hip replacement using the devices specified in this protocol
- Individuals with non-inflammatory degenerative joint disease (NIDJD) or any of its composite diagnoses of osteoarthritis, avascular necrosis, and posttraumatic arthritis
- Individuals who are willing and able to provide informed patient consent for participation in the study
- Individuals who are willing and able to return for follow-up as specified by the study protocol; and
- Individuals who are willing and able to complete the Subject Hip Outcomes questionnaire as specified by the study protocol
Who cannot take part
- Subject has participated in an IDE/IND clinical investigation, other than the COC28/COC36 IDE or PAS for their contralateral hip, with an investigational product in the last three months
- Evidence of active infections that may spread to other areas of the body (e.g.,osteomyelitis, pyogenic infection of the hip joint, overt infection, urinary tract infection, etc.)
- The presence of any known neoplastic (tumor-causing) or metastatic (spread of cancerous cells) disease
- Significant neurologic or musculoskeletal disorders or diseases that may adversely affect gait, weight bearing or postoperative recovery (e.g., muscular dystrophy, multiple sclerosis)
- Presence of highly communicable disease(s) that may limit follow-up (e.g., immuno-compromised conditions, hepatitis, active tuberculosis, etc.)
- Any condition that may interfere with postoperative recovery (e.g., Paget's disease, Charcot's disease)
- Use in patients with known allergies to the implant materials
- Inflammatory degenerative joint disease (like rheumatoid arthritis)
- Subject is a known drug or alcohol abuser or has a psychological disorder that could affect their ability to comply with protocol procedures and/or subject-completed questionnaires
- The Subject has a medical condition with less than 2 years of life expectancy
- Skeletally immature patients (tibial and femoral epiphyses not closed)
- Inadequate bone stock to support the device (e.g., severe osteopenia orosteoporosis)
- Poor skin coverage around the hip joint
- Marked atrophy (muscle and/or tissue loss) or deformity in the upper femur such as a birth defect affecting the leg bones
- Subject is currently involved in a personal injury litigation, medical-legal or worker's compensation claims
- The Subject is a woman who is pregnant or lactating
Where in United States
Also in 1 other country, 4 sites
- New England Baptist HospitalBoston, United StatesNo longer taking part
- Tufts New England Medical CenterBoston, United StatesNo longer taking part
- Orthopedic OneColumbus, United StatesNo longer taking part
- Colorado Joint ReplacementDenver, United StatesNo longer taking part
- Samuel Wellman, MD / Duke University Medical CenterDurham, United StatesNo longer taking part
- Arthroplasty FoundationLouisville, United StatesNo longer taking part
- UPennPhiladelphia, United StatesNo longer taking part
- Joint Surgeons of SacrementoSacramento, United StatesNo longer taking part
- Florida Orthopaedic InstituteTampa, United StatesNo longer taking part
About the trial
What the trial wants to find out
This study is intended to gather short (Pre-operative to 4-years) and mid-term (5-years) information regarding the performance and safety of the commercially available 36mm CERAMAX® Ceramic on Ceramic Total Hip System from a cohort of new study subjects that were not previously involved in the IDE study for this device.
The group in the trial
- CERAMAX COC 36mm Acetabular CupOther group
The CERAMAX 36mm ceramic acetabular bearing insert component is manufactured from high purity, dense alumina matrix composite ceramic.The insert is available in several inner diameter sizes, including 36mm; only 36mm inserts will be utilized in this PAS. The inserts secure to DePuy's Pinnacle acetabular shells by means of an interlocking mechanical taper.
Treatment: COC 36mm
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- 36mm CERAMAX® Ceramic Hip System PMA PAS STUDY: Short to Mid-Term Follow-up , New Study Subjects (Ceramic Hip System, Subjects Receive CERAMAX 36mm Ceramic Acetabular Bearing Insert That Articulates With a Ceramic Femoral Head for THA)
- Record updated
- 16 July 2025